Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literature

BACKGROUND: Retesting for Human epidermal growth factor receptor-2 (HER2) in post-neoadjuvant therapy resection is variable, and data is conflicting regarding the prognostic significance of changes in HER2 expression pre and post therapy. METHODS: We identified 104 patients with localized HER2 IHC 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Mogica, Jan Paredes, Tang, Haiming, Liang, Yuanxin, Zhong, Minghao, Hui, Pei, Harigopal, Malini, Krishnamurti, Uma, Fischbach, Neal A., Zhan, Haiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568274/
https://www.ncbi.nlm.nih.gov/pubmed/37812963
http://dx.doi.org/10.1016/j.breast.2023.103586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568274/
https://www.ncbi.nlm.nih.gov/pubmed/37812963
http://dx.doi.org/10.1016/j.breast.2023.103586

Ejemplares similares